Tatva Chintan Pharma Chem Limited (NSE:TATVA)
India · Delayed Price · Currency is INR 1,662.00
+7.00 (0.42%)
Nov 12, 2026, 3:29 PM IST
Tatva Chintan Pharma Chem Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Tatva Chintan Pharma Chem stock has a consensus rating of "Hold" and an average price target of ₹1,550. The average 1-year stock price forecast is 6.74% lower than the current stock price, while the lowest is ₹835.00 (-49.76%) and the highest is ₹2,385 (+43.50%).
Price Target: ₹1,550 (-6.74%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Tatva Chintan Pharma Chem stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Apr '26 | May '26 | Jul '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 3 | 3 | 3 | 3 | 4 | 4 |
Financial Forecast
Revenue This Year
7.13B
from 5.06B
Increased by 40.99%
Revenue Next Year
7.88B
from 7.13B
Increased by 10.44%
EPS This Year
33.10
from 17.98
Increased by 84.09%
EPS Next Year
40.97
from 33.10
Increased by 23.77%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.